TIBELLA
Identification of Tibella
| No description |
Google image searchProduct monograph
Active ingredient
tibolone, 2.5 MG
DIN: 02488361
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Schedule G (CDSA IV)
Company: BIOSYENT PHARMA INC
Date: 29-JUL-2020
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03C — ESTROGENS (ATC, ATC/DDD)
- G03CX — Other estrogens (ATC, ATC/DDD)
- G03CX01 — TIBOLONE (ATC/DDD)
Reference brand drug: Tibella
Pharmaceutical standard: MFR
